Elevance Health, Inc. 10-K

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. Market Information Our common stock, par value $0.01 per share, is listed on the NYSE under the symbol “ELV.” Holders As of February 1, 2024, there were 48,679 shareholders of record of our common stock. Securities Authorized for Issuance under Equity Compensation Plans The information required by this Item concerning securities authorized for issuance under our equity compensation plans is set forth in Part III, Item 12, “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” in this Annual Report on Form 10-K. Issuer Purchases of Equity Securities The following table presents information related to our repurchases of common stock for the periods indicated ( in millions, except share and per share data ): Period Total Number of Shares Purchased 1 Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Programs 2 Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs October 1, 2023 to October 31, 2023 216,670 $ 452.69 215,962 $ 5,031 November 1, 2023 to November 30, 2023 866,646 461.05 866,041 4,632 December 1, 2023 to December 31, 2023 914,923 473.05 912,664 4,200 1,998,239 1,994,667 1 Total number of shares purchased includes 3,572 shares delivered to or withheld by us in connection with employee payroll tax withholding upon exercise or vesting of stock awards. Stock grants to employees and directors and stock issued for stock option plans and stock purchase plans in the consolidated statements of shareholders’ equity are shown net of these shares purchased. 2 Represents the number of shares repurchased through the common stock repurchase program authorized by our Board of Directors, which the Board evaluates periodically. During the year ended December 31, 2023, we repurchased 5,773,932 shares at an aggregate cost of $2,676 under the program, including the cost of options to purchase shares. The Board of Directors has authorized our common stock repurchase program since 2003. On January 24, 2023, our Audit Committee, pursuant to authorization granted by the Board of Directors, authorized a $5,000 increase to our common stock repurchase program. No duration has been placed on our common stock repurchase program, and we reserve the right to discontinue the program at any time. -40- Performance Graph The following Performance Graph and related information compares the cumulative total return to shareholders of our common stock for the period from December 31, 2018 through December 31, 2023, with the cumulative total return over such period of (i) the Standard & Poor’s 500 Stock Index (the “S&P 500 Index”) and (ii) the Standard and Poor’s 500 Health Care Index (the “S&P 500 Health Care Index”). The graph assumes an investment of $100 on December 31, 2018 in each of our common stock and these indices (and the reinvestment of all dividends). The comparisons shown in the graph below are based on historical data, and we caution that the stock price performance shown in the graph below is not indicative of, and is not intended to forecast, the potential future performance of our common stock. Information used in the graph was obtained from S&P Global Market Intelligence, a source believed to be reliable, but we are not responsible for any errors or omissions in such information. The following graph and related information shall not be deemed “soliciting materials” or to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filing under the Exchange Act, except to the extent that we specifically incorporate it by reference into such filing. December 31, 2018 2019 2020 2021 2022 2023 Elevance Health, Inc. $ 100 $ 116 $ 125 $ 183 $ 205 $ 191 S&P 500 Index 100 131 156 200 164 207 S&P 500 Health Care Index 100 121 137 173 170 173 Based upon an initial investment of $100 on December 31, 2018 with dividends reinvested. -41- ITEM 6. [RESERVED]